Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 17/20 | 0.45 |
| ▸ | KIT | P10721 | 11/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.38 |
| ▸ | LCK | P06239 | 3/20 | 0.38 |
| ▸ | AXL | P30530 | 3/20 | 0.38 |
| ▸ | FLT3 | P36888 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | BMPR1B | O00238 | 2/20 | 0.38 |
| ▸ | PLK4 | O00444 | 2/20 | 0.38 |
| ▸ | STK25 | O00506 | 2/20 | 0.38 |
| ▸ | RIOK3 | O14730 | 2/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.38 |
| ▸ | GAK | O14976 | 2/20 | 0.38 |
| ▸ | DCLK1 | O15075 | 2/20 | 0.38 |
| ▸ | MUSK | O15146 | 2/20 | 0.38 |
| ▸ | EPHB6 | O15197 | 2/20 | 0.38 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.38 |
| ▸ | MAP3K13 | O43283 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4982409 | 0.90 | CSF1R (0.57) | CSF1RKITCYP2C9CYP2C19NTRK1 | |
| SCHEMBL2940149 | 0.88 | KIT (0.45) | CSF1RKITCYP2C19NTRK1LCK | |
| SCHEMBL18307002 | 0.82 | KIT (0.55) | CSF1RKITCYP2C19NTRK1LCK | |
| SCHEMBL4980504 | 0.81 | KIT (0.54) | CSF1RKITCYP2C19NTRK1LCK | |
| SCHEMBL4981745 | 0.81 | KIT (0.58) | CSF1RKITCYP2C19NTRK1LCK | |
| SCHEMBL2938195 | 0.81 | KIT (0.57) | CSF1RKITCYP2C19NTRK1LCK | |
| SCHEMBL1865625 | 0.80 | CSF1R (0.57) | CSF1RKITCYP2C19NTRK1LCK | |
| SCHEMBL1856316 | 0.80 | CSF1R (0.57) | CSF1RKITCYP2C19NTRK1LCK | |
| SCHEMBL14383789 | 0.80 | CSF1R (0.48) | CSF1RKIT | |
| SCHEMBL1856282 | 0.80 | CSF1R (0.57) | CSF1RKITCYP2C19NTRK1LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2222298-A1 | USE OF CFMS INHIBITOR FOR TREATING OR PREVENTING BONE CANCER AND THE BONE LOSS AND BONE PAIN ASSOCIATED WITH BONE CANCER | Janssen Pharmaceutica N.V. (BE) | 2010-09-01 | — | — | EP | disclosed |
| WO-2009058801-A1 | USE OF CFMS INHIBITOR FOR TREATING OR PREVENTING BONE CANCER AND THE BONE LOSS AND BONE PAIN ASSOCIATED WITH BONE CANCER | JANSSEN PHARMACEUTICA, N.V. (BE) | 2009-05-07 | — | — | WO | disclosed |